WGU D116 Advanced Pharmacology Objective Assessment OA
Question Bank (Latest 2026/2027 Edition) – 100% Correct
Questions, Answers & Detailed Rationales
Total Questions: 60
Time Allowed: 120 Minutes
Passing Score: Competency-Based (70%+)
Instructions: Select the BEST answer for each question based on advanced
pharmacology principles, pharmacokinetics, pharmacodynamics, and evidence-based
prescribing practices. For SATA questions, select all that apply.
──────────────────────────────
SECTION 1: FOUNDATIONAL PHARMACOLOGY & PHARMACOKINETICS
──────────────────────────────
Question 1
A 55-year-old patient with liver cirrhosis is prescribed propranolol 40 mg orally twice
daily for portal hypertension. The nurse practitioner recognizes that this patient's
first-pass metabolism will be significantly reduced. Which pharmacokinetic parameter is
most directly affected?
A. Bioavailability
B. Volume of distribution
C. Half-life
D. Renal clearance
Correct Answer: A
Rationale: The first-pass effect occurs when orally administered drugs are metabolized
by the liver before reaching systemic circulation. In cirrhosis, reduced hepatic function
decreases first-pass metabolism, increasing the fraction of unchanged drug that
,reaches systemic circulation—thereby increasing bioavailability. Volume of distribution,
half-life, and renal clearance are not primarily determined by first-pass metabolism.
Question 2
A patient receives a new antibiotic with a half-life of 24 hours. After 5 days of consistent
twice-daily dosing, the prescriber orders a peak and trough level. Approximately how
many half-lives have elapsed by this time?
A. 2 half-lives
B. 5 half-lives
C. 10 half-lives
D. 15 half-lives
Correct Answer: B
Rationale: Steady-state plasma concentration is typically achieved after 4 to 5 half-lives
of consistent dosing. With a 24-hour half-life, 5 days (120 hours) equals exactly 5
half-lives. This timing is appropriate for assessing drug levels at steady state. Fewer
half-lives would not achieve steady state.
Question 3
Which drugs or substances are known to inhibit the CYP3A4 enzyme system? Select all
that apply.
A. Ketoconazole
B. Rifampin
C. Grapefruit juice
D. Erythromycin
E. St. John's Wort
Correct Answers: A, C, D
Rationale: Ketoconazole, grapefruit juice, and erythromycin are potent CYP3A4
inhibitors that increase levels of substrates metabolized by this enzyme. Rifampin and
,St. John's Wort are CYP3A4 inducers that decrease substrate levels. Inhibition increases
the risk of toxicity for drugs such as simvastatin, amiodarone, and many calcium
channel blockers.
Question 4
A 70-year-old patient with hypoalbuminemia is prescribed warfarin. The nurse
practitioner understands that decreased protein binding will result in which effect?
A. Increased free drug concentration and increased pharmacologic effect
B. Decreased free drug concentration and decreased pharmacologic effect
C. Increased total drug concentration and no change in effect
D. Decreased volume of distribution and prolonged half-life
Correct Answer: A
Rationale: Warfarin is highly protein-bound (approximately 99%). In hypoalbuminemia,
less drug is bound to albumin, increasing the unbound (free) fraction. Only free drug is
pharmacologically active, so increased free drug concentration enhances anticoagulant
effect and bleeding risk. Total drug concentration may decrease as more free drug is
distributed and metabolized.
Question 5
A patient receives a loading dose of digoxin followed by a maintenance dose. The
loading dose is larger than subsequent doses primarily to achieve which goal?
A. Overcome the first-pass effect
B. Achieve therapeutic plasma concentration rapidly
C. Prevent renal excretion of the drug
D. Saturate plasma protein binding sites
Correct Answer: B
Rationale: A loading dose is an initial large dose administered to rapidly achieve
therapeutic plasma concentrations that would otherwise require multiple maintenance
, doses and 4-5 half-lives to reach steady state. It is not primarily used to overcome
first-pass metabolism, prevent excretion, or saturate protein binding.
Question 6
A patient with chronic kidney disease (eGFR 25 mL/min) is prescribed a renally
eliminated drug with a normal half-life of 4 hours. The nurse practitioner expects the
half-life in this patient to be:
A. Unchanged because half-life is an intrinsic drug property
B. Shorter because uremia increases hepatic metabolism
C. Longer because reduced renal clearance decreases elimination
D. Shorter because protein binding increases in renal failure
Correct Answer: C
Rationale: For drugs primarily eliminated by the kidneys, reduced renal function
decreases clearance, prolonging half-life. Half-life is determined by volume of
distribution and clearance (t½ = 0.693 × Vd / Cl). In renal failure, clearance decreases,
so half-life increases. Dose adjustment or extended dosing intervals are required to
prevent drug accumulation and toxicity.
Question 7
Which factors can increase the absorption of an orally administered drug? Select all that
apply.
A. Increased gastrointestinal blood flow
B. High-fat meal co-administration with a lipophilic drug
C. Concurrent use of a proton pump inhibitor for an acid-labile drug
D. Rapid gastrointestinal motility
E. Formulation as an enteric-coated tablet for a gastric-irritating drug
Correct Answers: A, B
Question Bank (Latest 2026/2027 Edition) – 100% Correct
Questions, Answers & Detailed Rationales
Total Questions: 60
Time Allowed: 120 Minutes
Passing Score: Competency-Based (70%+)
Instructions: Select the BEST answer for each question based on advanced
pharmacology principles, pharmacokinetics, pharmacodynamics, and evidence-based
prescribing practices. For SATA questions, select all that apply.
──────────────────────────────
SECTION 1: FOUNDATIONAL PHARMACOLOGY & PHARMACOKINETICS
──────────────────────────────
Question 1
A 55-year-old patient with liver cirrhosis is prescribed propranolol 40 mg orally twice
daily for portal hypertension. The nurse practitioner recognizes that this patient's
first-pass metabolism will be significantly reduced. Which pharmacokinetic parameter is
most directly affected?
A. Bioavailability
B. Volume of distribution
C. Half-life
D. Renal clearance
Correct Answer: A
Rationale: The first-pass effect occurs when orally administered drugs are metabolized
by the liver before reaching systemic circulation. In cirrhosis, reduced hepatic function
decreases first-pass metabolism, increasing the fraction of unchanged drug that
,reaches systemic circulation—thereby increasing bioavailability. Volume of distribution,
half-life, and renal clearance are not primarily determined by first-pass metabolism.
Question 2
A patient receives a new antibiotic with a half-life of 24 hours. After 5 days of consistent
twice-daily dosing, the prescriber orders a peak and trough level. Approximately how
many half-lives have elapsed by this time?
A. 2 half-lives
B. 5 half-lives
C. 10 half-lives
D. 15 half-lives
Correct Answer: B
Rationale: Steady-state plasma concentration is typically achieved after 4 to 5 half-lives
of consistent dosing. With a 24-hour half-life, 5 days (120 hours) equals exactly 5
half-lives. This timing is appropriate for assessing drug levels at steady state. Fewer
half-lives would not achieve steady state.
Question 3
Which drugs or substances are known to inhibit the CYP3A4 enzyme system? Select all
that apply.
A. Ketoconazole
B. Rifampin
C. Grapefruit juice
D. Erythromycin
E. St. John's Wort
Correct Answers: A, C, D
Rationale: Ketoconazole, grapefruit juice, and erythromycin are potent CYP3A4
inhibitors that increase levels of substrates metabolized by this enzyme. Rifampin and
,St. John's Wort are CYP3A4 inducers that decrease substrate levels. Inhibition increases
the risk of toxicity for drugs such as simvastatin, amiodarone, and many calcium
channel blockers.
Question 4
A 70-year-old patient with hypoalbuminemia is prescribed warfarin. The nurse
practitioner understands that decreased protein binding will result in which effect?
A. Increased free drug concentration and increased pharmacologic effect
B. Decreased free drug concentration and decreased pharmacologic effect
C. Increased total drug concentration and no change in effect
D. Decreased volume of distribution and prolonged half-life
Correct Answer: A
Rationale: Warfarin is highly protein-bound (approximately 99%). In hypoalbuminemia,
less drug is bound to albumin, increasing the unbound (free) fraction. Only free drug is
pharmacologically active, so increased free drug concentration enhances anticoagulant
effect and bleeding risk. Total drug concentration may decrease as more free drug is
distributed and metabolized.
Question 5
A patient receives a loading dose of digoxin followed by a maintenance dose. The
loading dose is larger than subsequent doses primarily to achieve which goal?
A. Overcome the first-pass effect
B. Achieve therapeutic plasma concentration rapidly
C. Prevent renal excretion of the drug
D. Saturate plasma protein binding sites
Correct Answer: B
Rationale: A loading dose is an initial large dose administered to rapidly achieve
therapeutic plasma concentrations that would otherwise require multiple maintenance
, doses and 4-5 half-lives to reach steady state. It is not primarily used to overcome
first-pass metabolism, prevent excretion, or saturate protein binding.
Question 6
A patient with chronic kidney disease (eGFR 25 mL/min) is prescribed a renally
eliminated drug with a normal half-life of 4 hours. The nurse practitioner expects the
half-life in this patient to be:
A. Unchanged because half-life is an intrinsic drug property
B. Shorter because uremia increases hepatic metabolism
C. Longer because reduced renal clearance decreases elimination
D. Shorter because protein binding increases in renal failure
Correct Answer: C
Rationale: For drugs primarily eliminated by the kidneys, reduced renal function
decreases clearance, prolonging half-life. Half-life is determined by volume of
distribution and clearance (t½ = 0.693 × Vd / Cl). In renal failure, clearance decreases,
so half-life increases. Dose adjustment or extended dosing intervals are required to
prevent drug accumulation and toxicity.
Question 7
Which factors can increase the absorption of an orally administered drug? Select all that
apply.
A. Increased gastrointestinal blood flow
B. High-fat meal co-administration with a lipophilic drug
C. Concurrent use of a proton pump inhibitor for an acid-labile drug
D. Rapid gastrointestinal motility
E. Formulation as an enteric-coated tablet for a gastric-irritating drug
Correct Answers: A, B
